AI assistant
REGENER8 RESOURCES NL — Proxy Solicitation & Information Statement 2026
Apr 1, 2026
65655_rns_2026-04-01_c536e313-0aab-42de-b04f-9d8022e9c34d.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
REGENER8 RESOURCES NL
ACN 655 560 740
NOTICE OF GENERAL MEETING
Notice is given that the General Meeting will be held at:
TIME : 10:00am (WST) DATE : 6 May 2026 PLACE : 104 Colin Street West Perth WA 6005
The business of the Meeting affects your shareholding and your vote is important.
This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 5pm (WST) on 4 May 2026.
IMPORTANT INFORMATION REGARDING MEETING ATTENDANCE AND VOTING
The Company will hold the Meeting as an in-person meeting at 104 Colin Street, West Perth WA 6005.
In accordance with recent amendments to the Corporations Act 2001 (Cth), the Company will not be dispatching physical copies of the Notice of Meeting unless the shareholder has made a valid election to receive documents in hard copy Instead, the Notice of Meeting and accompanying explanatory statement are being made available to shareholders electronically and can be viewed and downloaded from: https://www.asx.com.au/markets/company/r8r
All resolutions at the Meeting will be voted on by poll and Shareholders who are entitled to vote may vote either at the Meeting by poll or prior to the Meeting by appointing a proxy. Further details of the voting methods open to Shareholders are set out in detail below.
Shareholders are strongly encouraged to either vote prior to the Meeting or to appoint the Chair as their proxy.
Enquiries
Shareholders are requested to contact the Company Secretary on +61 (8) 9226 2011 if they have any queries in respect of the matters set out in this Notice of General Meeting or the Explanatory Statement.
Voting Eligibility
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 5.00pm (WST) on 4 May 2026.
Voting by poll
All votes taken at the Meeting will be conducted by way of a poll.
Voting by proxy
Shareholders should note that:
-
a member of the Company entitled to attend and vote at the Meeting is entitled to appoint a proxy;
-
a proxy need not be a member of the Company; and
-
a member of the Company entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise, but where the proportion or number is not specified, each proxy may exercise half of the votes.
The enclosed proxy form provides further details on appointing proxies and lodging proxy forms. To be valid, the proxy form (and any power of attorney under which it is signed) must be completed and returned by the time and in accordance with the instructions set out in the proxy form. Any proxy form received after that time will not be valid for the Meeting.
2
Subject to any voting restrictions set out in a voting exclusion statement in respect of the Resolutions, the Chair will vote undirected proxies on, and in favour of, each Resolution.
Corporate representatives
A body corporate may appoint an individual as its representative to exercise any of the powers the body may exercise at meetings of a company’s members. The appointment may be a standing one. Unless the appointment states otherwise, the representative may exercise all of the powers that the appointing body could exercise at a meeting or in voting on a resolution.
For representatives attending the Meeting, the representative must, prior to the Meeting, provide evidence of his or her appointment, to the Company by email to [email protected], by no later than 10:00am (WST) on 11 September 2024, the day prior to the Meeting, noting the authority under which the appointment is signed, unless it has previously been given to the Company. Representatives who wish to vote by poll during the Meeting must first notify the company secretary in accordance with the instructions set out above under ‘voting by poll’.
3
BUSINESS OF THE MEETING
AGENDA
1. RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES (7.1)
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution:
“That, for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 4,749,750 Placement Shares issued under Listing Rule 7.1 on the terms and conditions set out in the Explanatory Statement.”
A voting exclusion statement applies to this Resolution. Please see below.
2. RESOLUTION 2 - RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES (7.1A)
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution:
“That, for the purpose of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 3,250,250 Placement Shares issued under Listing Rule 7.1A on the terms and conditions set out in the Explanatory Statement.”
A voting exclusion statement applies to this Resolution. Please see below.
3. RESOLUTION 3 – APPROVAL TO ISSUE CONSIDERATION SHARES – SREBRENICA NORTH
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution:
“That, for the purpose of ASX Listing Rule 7.3 and for all other purposes, approval is given for the Company to issue up to 8,000,000 Consideration Shares to shareholders of Orichalcum d.o.o. on the terms and conditions set out in the Explanatory Memorandum.”
A voting exclusion statement applies to this Resolution. Please see below.
By order of the Board
Mr Matthew Foy Company Secretary 2 April 2026
4
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the resolution set out below by or on behalf of the following persons:
| RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES(7.1) |
Placement Participants or any other person who participated in the issue or an associate of that person or those persons. |
|---|---|
| RESOLUTION 2 – RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES(7.1A) |
Placement Participants or any other person who participated in the issue or an associate of that person or those persons. |
| RESOLUTION 3 – APPROVAL TO ISSUE CONSIDERATION SHARES – SREBRENICA NORTH |
Shareholders of Orichalcum d.o.o (and/or their respective nominees) or any other person who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) or an associate of that person or those persons. |
However, this does not apply to a vote cast in favour of the Resolution by:
-
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with the directions given to the proxy or attorney to vote on the Resolution in that way; or
-
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
-
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:
-
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the resolution; and
-
(ii) the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.
5
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
-
each Shareholder has a right to appoint a proxy;
-
the proxy need not be a Shareholder of the Company; and
-
a Shareholder who is entitled to cast two (2) or more votes may appoint two (2) proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints two (2) proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
-
if proxy holders vote, they must cast all directed proxies as directed; and
-
any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the Company Secretary on +61 (0) 475 296 121.
6
EXPLANATORY STATEMENT
This Explanatory Statement has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.
This Explanatory Memorandum has been prepared for the information of Shareholders in connection with the business to be conducted at the General Meeting to be held at 104 Colin Street, West Perth WA 6005 on Wednesday, 6 May 2026 at 10:00am (WST) ( Meeting ).
This Explanatory Memorandum should be read in conjunction with and forms part of the accompanying Notice. The purpose of this Explanatory Memorandum is to provide information to Shareholders in deciding whether or not to pass the Resolutions set out in the Notice.
A Proxy Form is located at the end of the Explanatory Memorandum.
1. RESOLUTIONS 1 AND 2 – RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES UNDER 7.1 AND 7.1A
1.1 General
On 3 March 2026 R8R announced it had entered into a binding agreement with shareholders of Orichalcum d.o.o. to acquire 100% of the issued capital of Orichalcum d.o.o ( Srebrenica North Agreement) which holds 100% of the Srebrenica North Project (Ag-Cu-Sb-Zn-Pb) in Bosnia and Herzegovina ( Project ).
In consideration for the acquisition of the Project the Company agreed to pay Orichalcum d.o.o consideration comprising $25,000 cash upon execution of the agreement and completion consideration of $50,000 cash plus eight million ordinary shares in R8R ( Consideration Shares ) to the Vendors (or their nominees) subject to shareholder approval.
On 5 March 2006, The Company announced that it had secured firm commitments to raise a total of $800,000 (before costs) through a placement of 8 million new shares to professional and sophisticated investors at an issue price of $0.10 per share ( Placement Shares ).
The Placement was strongly supported by new and existing investors and ensures the Company is well funded to advance acquisition and exploration programs at Srebrenica North Project (Ag-Cu-Sb-Zn-Pb) and its current portfolio.
On 12 March 2026 4,749,750 Placement Shares were issued pursuant to the Company’s existing placement capacity under Listing Rule 7.1 and 3,250,250 Placement Shares were issued pursuant to Listing Rule 7.1A.
Resolutions 1 and 2 seek Shareholder ratification for the prior issue of the Placement Shares under and for the purposes of Listing Rule 7.3. The effect of Resolutions 1and 2 will be to allow the Company to ratify the prior issue of Placement Shares, without using the Company's 15% and 10% annual placement capacity.
1.2 ASX Listing Rules 7.1 and 7.4
ASX Listing Rule 7.1 provides that a company must not, subject to specified exceptions, issue or agree to issue more equity securities during any 12 month
7
period than that amount which represents 15% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period.
ASX Listing Rule 7.1A provides that an eligible entity may seek shareholder approval at its annual general meeting to have the additional capacity to issue equity securities during any 12 month period up to that amount which represents 10% of the number of fully paid ordinary securities on issue at the commencement of that 12 month period, subject to that issue satisfying certain criteria.
Listing Rule 7.4 allows the shareholders of a listed company to ratify an issue of equity securities after it has been made or agreed to be made. If they do, the issue is taken to have been approved under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity securities without shareholder approval under that rule, the Company wishes to retain as much flexibility as possible to issue additional equity securities into the future without having to obtain shareholder approval for such issues under Listing Rule 7.1 and 7.1A.
The prior issue of the of the Placement Shares does not fit within any of the exception set out in Listing Rule 7.2 and, as it had not been approved by Shareholders, it effectively uses up part of the 25% limit in Listing Rules 7.1 and 7.1A, reducing the Company’s capacity to issue further equity securities without Shareholder approval under Listing Rule 7.1 and Listing Rule 7.1A for the 12 month period following the date of issue of the Placement Shares.
By ratifying the prior issue of the Placement Shares, the Company will retain the flexibility to issue equity securities in the future up to the 15% annual placement capacity set out in ASX Listing Rule 7.1 and up to the 10% additional placement capacity set out in ASX Listing Rule 7.1A without the requirement to obtain prior Shareholder approval.
Resolutions 1 and 2 seek Shareholder ratification of the prior issue of the Placement Shares under ASX Listing Rule 7.1 and ASX Listing Rule 7.1A respectively.
1.3 Technical Information required by ASX Listing Rule 14.1A
If Resolutions 1 and 2 are passed, the Placement Shares will be excluded in calculating the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of issue of the Placement Shares.
If Resolution 1 and 2 are not passed, the Placement Shares will be included in calculating the Company’s combined 25% limit in Listing Rule 7.1 and 7.1A, effectively decreasing the number of equity securities the Company can issue without Shareholder approval over the 12 month period following the date of issue of the Placement Shares.
1.4 Technical Information required by ASX Listing Rule 7.5
Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to Placement Shares:
- (a) The Placement Shares have been issued to professional and sophisticated investors (or nominee) identified by CPS Capital Group Pty Ltd, who are not related parties of the Company or a person to whom Listing Rule 10.11 applies.
8
-
(b) No applicant for the Placement Shares was a member of the Company’s key management personnel. Substantial shareholder Timothy Neesham participated in the offer and subscribed for more than 1% of the entity’s current issued capital in the Placement. In addition, an entity associated with Mr Tolga Kumova subscribed for more than 1% of the entity’s current issued capital in the Placement.
-
(c) The total number of securities issued was 8 million ordinary shares that rank parri passu with the existing class of ordinary shares on issue. A total of 4,749,750 shares were issued pursuant to Listing Rule 7.1 and 3,250,250 shares were issued pursuant to Listing Rule 7.1A.
-
(d) The Placement Shares were issued at a price of $0.10 per share raising a total of $800,000 (before costs) through the placement.
-
(e) The Placement Shares were not issued under an agreement.
-
(f) The purpose of the issue was to raise capital which will be used to advance acquisition and exploration programs at Srebrenica North Project.
-
(g) The Placement Shares were issued on 12 March 2026.
-
(h) A voting exclusion statement is included in Resolution 1 and Resolution 2 of the Notice.
The Directors of the Company believe Resolution 1 and Resolution 2 are in the best interest of the Company and its Shareholders and unanimously recommend that the Shareholders vote in favour of both these Resolutions.
2. RESOLUTION 3 APPROVAL TO ISSUE CONSIDERATION SHARES
2.1 General
As set out in 1.1 above, the Company announced it had entered into a binding agreement with shareholders of Orichalcum d.o.o. to acquire 100% of the issued capital of Orichalcum d.o.o that holds 100% of the Srebrenica North Project.
2.2 ASX Listing Rules 7.1 and 7.4
A summary of Listing Rule 7.1 is set out in Section 1.2 above.
The proposed issue falls within exception 17 of Listing Rule 7.2. It therefore requires the approval of Shareholders under Listing Rule 7.1.
2.3 Technical Information required by ASX Listing Rule 14.1A
If Resolution 3 is passed, the Company will be able to proceed with the issue of Consideration Shares. In addition, the issue will be excluded from the calculation of the number of equity securities that the Company can issue without Shareholder approval under Listing Rule 7.1.
If Resolution 3 is not passed, the Company will not be able to proceed with the issue of the Consideration Shares. As a result, the Company would not be able to
9
proceed with the acquisition of the Srebrenica North Project under the current terms.
2.4 Technical Information required by ASX Listing Rule 7.3
Pursuant to and in accordance with ASX Listing Rule 7.3, the following information is provided in relation to Consideration Shares:
-
(a) The Consideration Shares will be issued to the two shareholders of Orichalcum d.o.o (or their nominee) being Mr Nenad Toholj and Mr Boban Jolovic who are not a related parties of the Company or a person to whom Listing Rule 10.11 applies.
-
(b) The number of securities to be issued are a total of up to 8 million ordinary shares that rank parri passu with the existing class of ordinary shares on issue.
-
(c) The Consideration Shares will be issued in part consideration for the acquisition of the Project. Accordingly, no funds will be raised from the issue of the Consideration Shares. Details of the terms of the Srebrenica North Agreement are included in 1.1 above.
-
(d) The Consideration Shares are intended to be issued on completion of the Srebrenica North Agreement in any case not later than 3 months after this meeting.
-
(e) A voting exclusion statement is included in Resolution 3 of the Notice.
The Directors of the Company believe Resolution 3 are in the best interest of the Company and its Shareholders and unanimously recommend that the Shareholders vote in favour of this Resolution.
10
GLOSSARY
$ means Australian dollars.
Agreement has the meaning set out in section 1.1.
ASIC means the Australian Securities & Investments Commission.
Associated Body Corporate means:
-
(i) a related body corporate (as defined in the Corporations Act) of the Company;
-
(ii) a body corporate which has an entitlement to not less than 20% of the voting Shares of the Company; and
-
(iii) a body corporate in which the Company has an entitlement to not less than 20% of the voting shares.
ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.
ASX Listing Rules or Listing Rules means the listing rules of ASX.
Board means the current board of directors of the Company.
Business Day means Monday to Friday inclusive, except New Year’s Day, Good Friday, Easter Monday, Christmas Day, Boxing Day, and any other day that ASX declares is not a business day.
Chair means the chair of the Meeting.
Closely Related Party of a member of the Key Management Personnel means:
-
(a) a spouse or child of the member;
-
(i) a child of the member’s spouse;
-
(ii) a dependent of the member or the member’s spouse;
-
(iii) anyone else who is one of the member’s family and may be expected to influence the member, or be influenced by the member, in the member’s dealing with the entity;
-
(iv) a company the member controls; or
-
(v) a person prescribed by the Corporations Regulations 2001 (Cth) for the purposes of the definition of ‘closely related party’ in the Corporations Act.
Company means Regener8 Resources NL (ACN 655 560 740).
Consideration Shares has the meaning set out in section 1.1.
Constitution means the Company’s constitution.
Corporations Act means the Corporations Act 2001 (Cth).
11
Directors means the current directors of the Company.
Equity Securities has the same meaning as in the Listing Rules.
Explanatory Statement means the explanatory statement accompanying the Notice.
General Meeting or Meeting means the meeting convened by the Notice.
Listing Rules means the Listing Rules of ASX.
Notice or Notice of Meeting means this notice of meeting including the Explanatory Statement and the Proxy Form.
Srebrenica North Agreement has the meaning set out in section 1.1.
Placement Shares has the meaning set out in section 1.1.
Proxy Form means the proxy form accompanying the Notice.
Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.
Section means a section of the Explanatory Statement.
Share means a fully paid ordinary share in the capital of the Company.
Shareholder means a registered holder of a Share.
WST means Western Standard Time as observed in Perth, Western Australia.
12
Regener8 Resources NL | ABN 93 655 560 740
==> picture [138 x 58] intentionally omitted <==
Proxy Voting Form If you are attending the Meeting in person, please bring this with you
for Securityholder registration.
Your proxy voting instruction must be received by 10:00am (AWST) on Monday, 04 May 2026 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.
SUBMIT YOUR PROXY
Complete the form overleaf in accordance with the instructions set out below.
YOUR NAME AND ADDRESS
The name and address shown above is as it appears on the Company’s share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal: https://investor.automic.com.au/#/home Shareholders sponsored by a broker should advise their broker of any changes.
STEP 1 - APPOINT A PROXY
If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.
DEFAULT TO THE CHAIR OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting, who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.
Lodging your Proxy Voting Form:
Online
Use your computer or smartphone to appoint a proxy at https://investor.automic.com.au/#/loginsah or
scan the QR code below using your smartphone
Login & Click on ‘Meetings’. Use the Holder Number as shown at the top of this Proxy Voting Form.
==> picture [58 x 58] intentionally omitted <==
STEP 2 - VOTES ON ITEMS OF BUSINESS
You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.
APPOINTMENT OF SECOND PROXY
You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services.
SIGNING INSTRUCTIONS
Individual: Where the holding is in one name, the Shareholder must sign. Joint holding: Where the holding is in more than one name, all Shareholders should sign. Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it.
Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you.
Email Address: Please provide your email address in the space provided.
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email.
CORPORATE REPRESENTATIVES
If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate Representative’ should be produced prior to admission. A form may be obtained from the Company’s share registry online at https://automicgroup.com.au.
BY MAIL:
Automic GPO Box 5193 Sydney NSW 2001
IN PERSON:
Automic Level 5, 126 Phillip Street Sydney NSW 2000
BY EMAIL:
BY FACSIMILE:
+61 2 8583 3040
All enquiries to Automic: WEBSITE:
https://automicgroup.com.au
PHONE:
1300 288 664 (Within Australia) +61 2 9698 5414 (Overseas)
STEP 1 - How to vote
APPOINT A PROXY:
I/We being a Shareholder entitled to attend and vote at the General Meeting of Regener8 Resources NL, to be held at 10:00am (AWST) on Wednesday, 06 May 2026 at 104 Colin Street West Perth WA 6005 hereby:
==> picture [37 x 171] intentionally omitted <==
Appoint the Chair of the Meeting (Chair) to vote in accordance with the following directions (or if no directions have been given, and subject to the relevant laws, as the Chair sees fit) at this meeting and at any adjournment thereof. Please note: If you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy. If the person so named is absent from the meeting, or if no person is named, the Chair will act on your behalf. The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is entitled to vote. Unless indicated otherwise by marking the “for”, “against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention.
STEP 2 - Your voting direction
| PL Resolutions For Against Abstain 1 RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES (7.1) 2 RATIFICATION OF PRIOR ISSUE OF PLACEMENT SHARES (7.1A) 3 APPROVAL TO ISSUE CONSIDERATION SHARES – SREBRENICA NORTH Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution and your votes will not be counted in computing the required majority on a poll. |
|---|
==> picture [539 x 180] intentionally omitted <==
----- Start of picture text -----
STEP 3 – Signatures and contact details
Individual or Securityholder 1 Securityholder 2 Securityholder 3
Sole Director and Sole Company Secretary Director Director / Company Secretary
Contact Name:
Email Address:
Contact Daytime Telephone Date (DD/MM/YY)
/ /
By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible).
----- End of picture text -----